Abstract
Cancer drug resistance is a major challenge in cancer treatment, often leading to treatment failure and disease relapse. This article explores the genetic drivers of drug resistance in cancer, focusing on the mutations, gene amplifications, and epigenetic alterations that contribute to resistance. We examine the mechanisms through which these genetic changes impact drug efficacy, as well as the strategies being developed to overcome resistance. The article also discusses the implications of these findings for precision medicine and the future of cancer therapy.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Dr. Ethan Roberts (Author)